1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complex association between social support and chemotherapy-related toxicities in older cancer patients
    Meeting Abstract

    Shahrokni, A.; Sun, C.; Tew, W. P.; Mohile, S. G.; Owusu, C.; Klepin, H. D.; Gross, C. P.; Lichtman, S. M.; Gajra, A.; Katheria, V.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Assessing the clinical feasibility of electronic Rapid Fitness Assessment (eRFA): A novel geriatric assessment tool for the oncology setting
    Meeting Abstract

    Shahrokni, A.; Vickers, A. J.; Mahmoudzadeh, S.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Segal, N. H.; Kemeny, N. E.; Cercek, A.; Reidy, D. L.; Raasch, P. J.; Warren, P.; Hrabovsky, A. E.; Campbell, N.; Shia, J.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Do pancreatic cancer (PDA) stem cell markers predict biologic behavior?
    Meeting Abstract

    Sahin, I. H.; Turkekul, M.; Capanu, M.; Askan, G.; McMahon, B.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Expression levels of aldehyde dehydrogenase 1A1 (ALDH1A1) in circulating tumor and invasive cells (CTICs) as a biomarker for drug resistance and disulfiram in pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Ricigliano, M.; Cooper, B.; Ocean, A. J.; Tiriac, H.; Tuveson, D. A.; Yu, K. H.; O'Reilly, E. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety and efficacy of lanreotide depot/autogel (LAN) in patients with lung NETs: The randomized, double-blind, placebo (PBO)-controlled phase III SPINET study
    Meeting Abstract

    Reidy, D. L.; Kulke, M. H.; Wolin, E. M.; Singh, S.; Ferone, D.; Mirakhur, B.; Massien, C.; Houchard, A.; Caplin, M. E.; Baudin, E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT
    Meeting Abstract

    Raj, N. P.; Soumerai, T.; Valentino, E.; Hechtman, J. F.; Berger, M. F.; Reidy, D. L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Updated phase 1 results
    Meeting Abstract

    O'Reilly, E. M.; Mahalingam, D.; Roach, J. M.; Miller, P. J.; Rosano, M. E.; Krause, S.; Wolf, J.; Flaherty, K.; Ryan, D. P.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 2, open-label, multicenter study of durvalumab (MEDI4736) ± tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS
    Meeting Abstract

    O'Reilly, E. M.; Oh, D. Y.; Lee, M. A.; Dhani, N.; Armstrong, J.; Belli, R.; Ferro, S.; Ben, Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC)
    Meeting Abstract

    Meric-Bernstam, F.; Tannir, N. M.; Mier, J. W.; DeMichele, A.; Telli, M. L.; Fan, A. C.; Munster, P. N.; Carvajal, R. D.; Orford, K. W.; Bennett, M. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save